Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 681.78

+1.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (274)	3/24/1999 9:48:00 AM
From: scaram(o)uche	Read Replies (2) of 3557

We seem to have four classes of CEOs in biotech right now..... 25% running semi-scams 15% too stupid to scratch where it itches 55% running good operations, but caught in the headlights 5% keeping their programs on target, innovating to fit the business plan to conditions It's the "caught in the headlights" category that irks me the most. It's been obvious that one needed to merge the good U.S. companies to create "british-like" companies. That is, we need to have companies with broader pipelines moving forward. Lots of the British pipelines were weak, but there was temporary strength added to the business plans through diversity of the preclinical and clinical projects. It's really beginning to bug me, as I own a lot of "55%" companies....... egos and blinders are getting in the way of the sector's vitality.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next